Excretion rate and composition of skin surface lipids on the foreheads of adult males with type IV hyperlipoproteinemia

Turkish Journal of Medical Sciences

Volumn 37, Issue 4, 2007, Pages 205-211

  Güldür, Tayfun ^a   Bayraktar, Nihayet ^a   Kaynar, Özgür ^b   Beker, Gülçin ^a   Koçer, Muzaffer ^a   Özcan, Hamdi ^a  

^a INONU UNIVERSITY   (Turkey)

^b ATATÜRK UNIVERSITY   (Turkey)

Author keywords

Human; Hyperlipoproteinemia; Sebaceous gland; Sebum lipid

Indexed keywords

CELLS; CONCENTRATION (PROCESS); GLYCEROL; PROTEINS; SAMPLING; THIN LAYER CHROMATOGRAPHY;

HYPERLIPOPROTEINEMIA; SEBACEOUS GLANDS; SEBUM LIPIDS; SURFACE LIPIDS;

LIPIDS;

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; CHOLESTEROL ESTER; ESTER; HEXANE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; WAX;

ADULT; AGAR GEL ELECTROPHORESIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FOREHEAD; HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; HYPERLIPOPROTEINEMIA TYPE 4; LIPID ANALYSIS; MALE; QUANTITATIVE ANALYSIS; SEBACEOUS GLAND; SEBUM SECRETION; SKIN SURFACE;

EID: 34548669633     PISSN: 13000144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Nicolaides N. Skin lipids: their biochemical uniqueness. Science 1974; 186: 19-26.
2. Thody AJ, Shuster S. Control and function of sebaceous glands. Physiological Reviews 1989; 69: 383-416.
3. Pochi PE, Strauss JS. Endocrinologic control of the development and activity of the human sebaceous gland. J Invest Dermatol 1974; 62: 191-201.
4. Pochi PE, Strauss JS, Downing DT. Age-related changes in sebaceous gland activity. J Invest Dermatol 1979; 73: 108-111.
5. Strauss JS, Pochi PE. The quantitative gravimetric determination of sebum production. J Invest Dermatol 1961; 36: 293-298.
6. Stewart ML, Steele WA, Downing DT. Changes in the relative amounts of endogenous and exogenous fatty acids in sebaceous lipids during early adolescence. J Invest Dermatol 1989; 92: 371-378.
7. Nikkari T, Schreibman PH, Ahrens H. Isotope kinetics of human skin cholesterol secretion. J Exp Med 1975; 141: 620-634.
8. Jong MC, Gijbels MJJ, Dahlmans VEH, van Gorp PJJ, Kopman SJ, Ponec M et al. Hyperlipidemia and cutaneous abnormalities in transgenic mice overexpressing human apolipoprotein C1. J Clin Invest 1998; 101: 145-152.
9. Fex GA, Aronsson A, Andersson A, Larsson K, Nilsson-Ehle P. In vivo effects of 13-cis retinoic acid treatment on the concentration of proteins and lipids in serum. Eur J Clin Chem Clin Biochem 1996; 34: 3-7.
10. Laker MF, Green C, Bhuiyan AK, Shuster S. Isotretinoin and serum lipids: studies on fatty acid, apolipoprotein and intermediary metabolism. Br J Dermatol 1987; 117: 203-206.
11. Rifal N, Bachorik PS, Albers JJ. Lipids, lipoproteins and apolipoproteins. In: Burtis CA, Ashwood E, editors. Tietz textbook of clinical chemistry. 3rd ed. USA: WB Saunders Company; 1999. p. 831.
12. Röpke EM, Augustin W, Gollnick H. Improved method for studying skin lipid samples from cyanoacrylate strips by high performance thin layer chromatography. Skin Pharmacol 1996; 9: 381-387.
13. Menlik BC, Hollmann J, Erler E, Verhoeven B, Plewig G. Microanalytical screening of all major stratum corneum lipids by sequential high-performance thin-layer chromatography. J Invest Dermatol 1989; 92: 231-234.
14. Strauss JS, Pochi PE, Downing DT. The sebaceous glands: twenty-five years of progress. J Invest Dermatol 1976; 67: 90-97.
15. Nordstrom KM, Schmus HG, McGinley KJ, Leyden JJ. Measurement of sebum output using a lipid absorbent tape. J Invest Dermatol 1986; 87: 260-263.
16. Guy R, Ridden C, Kealey T. The improved organ maintenance of the human sebaceous gland: modeling in vitro the effects of epidermal growth factor, androgens, estrogens, 13-cis retinoic acid, and phenol red. J Invest Dermatol 1996; 106: 454-460.
17. Stewart ME, Downing DT, Pochi PE, Strauss JS. The fatty acids of human sebaceous gland phosphatidylcholine. Biochimica et Biophysica Acta 1978; 529: 380-386.
18. Ebling FJ. Hormonal control and methods of measuring sebaceous gland activity. J Invest Dermatol 1974; 62: 161-171.
19. Shuster S, Thody AJ. The control and measurement of sebum secretion. J Invest Dermatol 1974; 62: 172-190.
20. Cooper MF, McGrath H, Shuster S. Sebaceous lipogenesis in human skin. Br J Dermatol 1976; 94:165-172.
21. Cheng JB, Russell DW. Mammalian wax biosynthesis: I. Identification of two fatty acyl-coenzyme A reductases with different substrate specificities and tissue distributions. J Biol Chem 2004; 279: 37789-37797.
22. Cheng JB, Russell DW. Mammalian wax biosynthesis: II. Expression cloning of wax synthase cDNAs encoding a member of the acyltransferase enzyme family. J Biol Chem 2004; 279: 37798-37807.
23. Stalenhoef AF, Demacker PN, Lutterman JA, van't Laar A. Plasma lipoproteins, apolipoproteins, and triglyceride metabolism in familial hypertriglyceridemia. Arteriosclerosis 1986; 6: 387-394.
24. Packard CJ, Shepherd J, Joerns S, Gotto AM, Taunton OD. Apolipoprotein B metabolism in normal, type IV, and type V hyperlipoproteinemic subjects. Metabolism 1980; 29: 213-222.
25. Brunzell JD, Albers JJ, Chait A, Grundy SM. Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia. J Lipid Res 1983; 24: 147-155.
26. Brook JG, Lavy A, Aviram M, Zinder O. The concentration of high density lipoprotein in patients with type IV hyperlipoproteinemia and effect of clofibrate. Atherosclerosis 1980; 36: 461-469.
27. Smythe CDW, Greenall M, Kealey T. The activity of HMG-CoA reductase and acetyl-CoA carboxylase in human apocrine sweat glands, sebaceous glands, and hair follicles is regulated by phosphorylation and by exogenous cholesterol. J Invest Dermatol 1998; 111: 139-148.
28. Cunliffe WJ, Shuster S. The effect of inhibitors of cholesterol synthesis on sebum secretion in patients with acne. Br J Derm 1969; 81: 280-282.
29. Marcoux CM, Tremblay M, Nakajima K, Davignon J, Cohn JS. Characterization of remnant like particles isolated by immunoaffinity gel from the plasma of type III and type IV hyperlipoproteinemic patients. J Lipid Res 1999; 40: 636-647.
30. Marcoux C, Tremblay M, Fredenrich A, Jacques H, Krimbou L, Nakajima K, Davignon J, Cohn JS. Plasma remnant like particle lipid and apolipoprotein levels in normolipidemic and hyperlipidemic subjects. Atherosclerosis 1998; 139: 161-171.